Residency · Las Vegas, NV
Sponsored by Kirk Kerkorian School of Medicine at UNLV
Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective.
Journal of medical economics · 2022 · 61 citations · Ann Childress
Effectiveness of a digital therapeutic as adjunct to treatment with medication in pediatric ADHD.
NPJ digital medicine · 2021 · 60 citations · Ann Childress
Centanafadine for Attention-Deficit/Hyperactivity Disorder in Adolescents: A Randomized Clinical Trial.
Journal of the American Academy of Child and Adolescent Psychiatry · 2026 · 7 citations · Ann Childress
A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder.
CNS drugs · 2022 · 40 citations · Ann Childress
Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective.
Journal of managed care & specialty pharmacy · 2022 · 40 citations · Ann Childress
From Consensus Statement to Pills to Pixels: New Innovations in Attention-Deficit/Hyperactivity Disorder Care.
Journal of child and adolescent psychopharmacology · 2024 · 14 citations ·
Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD.
Current medical research and opinion · 2023 · 16 citations · Ann Childress
Real world analysis of treatment change and response in adults with attention-deficit/hyperactivity disorder (ADHD) alone and with concomitant psychiatric comorbidities: results from an electronic health record database study is the United States.
BMC psychiatry · 2024 · 9 citations · Ann Childress